Category: Joint ventures/collaborations
-
Genomics Company, Amazon Partner on Generative A.I.
A genomics company is providing precision medicine analytics from its databases with generative A.I. based on large language models from Amazon Web Services.
-
Biosensor Developed to Detect Explosives, Land Mines
Researchers from a university biochemistry lab and company developing synthetic enzymes designed techniques using engineered bacteria to detect buried land mines at longer distances.
-
Fujitsu, Linux Foundation Partner on Open-Source A.I.
I.T. systems company Fujitsu Ltd. is providing artificial intelligence model generation and fairness assessment software as open-source projects hosted by the Linux Foundation.
-
University Start-Up Developing Inhaled Gene Therapies
A new company spun-off from a university lab consortium is advancing gene therapies delivered through the lungs to treat rare inherited respiratory diseases.
-
Neurons from Stem Cells Produced for Overdose Therapy Tests
Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies.
-
NIH Challenge Seeks Early Alzheimer’s Indicators with A.I.
A new crowdsourced competition seeks more robust early indicators of Alzheimer’s disease and related dementias using analytics powered by artificial intelligence.
-
Venture Firm, Cancer Center Start Antibody Biotech Company
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets.
-
Infographic – Planned Moon Missions Through 2030
The Jaxa space agency from Japan plans a landing later this year, while NASA from the U.S. also expects to launch an orbital mission to the moon this year.
-
Grant Funds Typhoid Vaccine Patch Development
A health research foundation grant is funding development of a vaccine protecting against typhoid fever, given in a patch from from a spring-loaded device.
-
HHS Directs $100M for Covid-19 Venture Investments
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19.